Financhill
Back

Merck & Stock Predictions

Merck & Stock Forecast

  • Over the next 52 weeks, Merck & has on average historically risen by 10.8% based on the past 51 years of stock performance.
  • Merck & has risen higher in 32 of those 51 years over the subsequent 52-week period, corresponding to a historical accuracy of 62.75%
  • Is Merck & Stock Undervalued?
    The current Merck & [MRK] share price is $129.45. The Score for MRK is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
  • MRK is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Merck & Stock Go Up Next Year?

  • Over the next 52 weeks, Merck & has on average historically risen by 10.8% based on the past 51 years of stock performance.

Merck & Stock Rating

Buy
58
Merck & (MRK) is a Buy

Is Merck & overpriced?

  • Merck & has risen higher in 32 of those 51 years over the subsequent 52-week period, corresponding to a historical accuracy of 62.75%

Merck & Stock Price History

Is MRK stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MRK is experiencing slight selling pressure.

Stock Info

Exchange:
S&P500
Country:
United States
Industry:
Drug Manufacturers - General
Sector:
Healthcare
Type:
stock
Website:
merck.com

52-Week Data

52-Week High:
130.24
52-Week Low:
99.14

Prediction Charts

Market Cap:
328.03B
Price in USD:
129.45
Volume:
5.15M
Beta:
0.64

Technical Analysis

SMA50:
118.18
SMA100:
110.61
SMA200:
110.11
52-Wk Change:
17.05%

Stock Predictions

  • Is Merck & stock public?
    Yes, Merck & is a publicly traded company.
  • What is the Merck & stock quote today?
    The Merck & stock price is 129.45 USD today.
  • How to buy Merck & stock online?
    You can buy Merck & shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Feb-5 126.98 126.18 127.80 125.70
Feb-6 126.61 126.88 127.52 126.07
Feb-7 126.90 127.47 128.06 126.50
Feb-8 127.32 126.61 127.48 125.95
Feb-9 126.22 125.45 126.69 125.04
Feb-12 125.00 125.34 125.48 124.40
Feb-13 125.98 125.43 126.86 124.48
Feb-14 125.61 125.82 126.03 124.82
Feb-15 125.97 126.54 127.23 125.95
Feb-16 126.50 127.79 128.09 126.17
Feb-20 128.13 127.37 129.29 127.21
Feb-21 127.44 128.12 128.16 126.80
Feb-22 128.15 129.26 129.72 127.65
Feb-23 129.79 129.45 130.24 128.86

Merck & Earnings

Merck & Earnings Report: Per Share Merck & Earnings Q1 Q2 Q3 and Q4 last year and next year.

Merck & Forecast Revenue Growth

Merck & Stock Analysis: Historical quarterly revenues per share for Merck & and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.39 per share, a decrease next quarter of $0.14 per share, an increase this year of $7.18 per share, and an increase next year of $1.17 per share.

* Merck & stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.